Work

Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas

Year: 2020

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2020-140991

Authors: Brandon S. Imber, Miguel-Angel Perales, Jessica Flynn, Josel D Ruiz, Sean Devlin, Ana Alarcon Tomas, Carla Hajj, Connie Lee Batlevi, Parastoo B. Dahi, Richard J Lin, Jae H. Park, Michael Scordo, Gunjan L. Shah, Sergio A. Giralt, Craig S. Sauter, M. Lia Palomba, Joachim Yahalom

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096184947

FWCI: 0.1

Cites:

Cited by: 2

Related to: 10